Delving into the Latest Updates on Chongqing Huading Modern Biopharmaceutics Co. Ltd. with Synapse

Overview

Tags

Neoplasms

Digestive System Disorders

Other Diseases

Chemical drugs

Small molecule drug

Antibody

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	3
Infectious Diseases	2
Immune System Diseases	1

Top 5 Drug Type	Count

Chemical drugs	4
Small molecule drug	2
Antibody	1

Top 5 Target	Count

VEGF(Vascular endothelial growth factor)	1
LANCL2(LanC like 2)	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Apr 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

4

2

Phase 1

Approved

1

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Hematoporphyrin	Neoplasms More	Approved
ML-PHOTOXNEO01	Bile Duct Neoplasms More	Phase 1
ML-CA-06 ( VEGF )	Neoplasms More	Phase 1
ML-PHOTOXPH03	Dystrophy, Macular More	Preclinical
ML-PHOTOXDER02	Port-Wine Stain More	Preclinical